Protective Role of Exosomes Derived from Regulatory T Cells Against Inflammation and Apoptosis of BV-2 Microglia Under Oxygen-glucose Deprivation/reperfusion Challenge
Overview
Affiliations
Regulatory T cells (Tregs) are found to participate in the pathogenesis of cerebral ischemic stroke. Exosomes derived from Tregs (Treg-Exos) were found to mediate the mechanism of Tregs' roles under various physiological and pathological conditions. But the roles of Treg-Exos in cerebral ischemic stroke are still unclear. Here, we explored the protective effects of Treg-Exos against microglial injury in response to oxygen-glucose deprivation/reperfusion (OGD/R) exposure. The results showed that Tregs-Exos relieved OGD/R-caused increases in LDH release and caspase-3 activity in BV-2 cells. The decreased cell viability and increased percentage of TUNEL-positive cells in OGD/R-exposed BV-2 cells were attenuated by Tregs-Exos treatment. Tregs-Exos also suppressed OGD/R-induced increase in production of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 in BV-2 microglia. Furthermore, Tregs-Exos induced the expression levels of phosphorylated phosphatidylinositol-3-kinase (p-PI3K) and phosphorylated protein kinase B (p-Akt) in BV-2 microglia under the challenge of OGD/R. Inhibition of the PI3K/Akt signaling by LY294002 partly reversed the effects of Tregs-Exos on cell apoptosis and inflammation in OGD/R-exposed BV-2 microglia. These results indicated that Tregs-Exos exerted protective effects against the OGD/R-caused injury of BV-2 microglia by activating the PI3K/Akt signaling.
Exosome Source Matters: A Comprehensive Review from the Perspective of Diverse Cellular Origins.
Chen Y, Qi W, Wang Z, Niu F Pharmaceutics. 2025; 17(2).
PMID: 40006514 PMC: 11858990. DOI: 10.3390/pharmaceutics17020147.
Intermittent hypoxic training - derived exosomes in stroke rehabilitation.
Ryou M, Burton S Front Integr Neurosci. 2024; 18:1475234.
PMID: 39323911 PMC: 11422222. DOI: 10.3389/fnint.2024.1475234.
Li P, Yin R, Chen Y, Chang J, Yang L, Liu X J Nanobiotechnology. 2023; 21(1):396.
PMID: 37904204 PMC: 10617166. DOI: 10.1186/s12951-023-02114-8.